Skip to main content
Premium Trial:

Request an Annual Quote

Xenon Genetics Eyes IPO Within 18 Months

SAN FRANCISCO, Jan. 7 - Xenon Genetics, a privately held genomics-based drug-discovery company, said on Monday that it will attempt and initial public offering in 12 to 18 months.

 

The firm also said it plans to collaborate this year with a "major pharmaceutical or biotech company" in a deal similar to the research relationship it forged with Pfizer. In this arrangement, whose financial details remain undisclosed, researchers from Xenon and Pfizer's Warner-Lambert subsidiary try to uncover genomic-based targets that would increase HDL cholesterol and lower triglycerides.

 

Frank Holler, Xenon's president and CEO, would not say what those companies are. He spoke at the 20th annual JPMorgan H&Q Healthcare Conference, held here through Thursday.

 

Last month, Xenon, based in Vancouver, said it had discovered a gene related to epilepsy and one that is associated with iron metabolism regulation.

 

The epilepsy gene was found through genetic analysis of families with a form of epilepsy called idiopathic generalized epilepsy. The finding was then validated clinically in humans, according to the company.

 

The second gene was identified through an animal model and validated as an iron metabolism regulator in humans.

 

Xenon said both genes were found to be drug targets for possible therapies for treating iron disorders and epilepsy.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.